Francine Foss, MD
Yale University
6
5
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Nancy Bartlett, MD
Washington University School of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Sareeta S Parker, MD
Emory University
Shared therapeutic areas:
Worked with same sponsors:
Alan B Fleischer, Jr., MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Worked with same sponsors:
Nashat Gabrail, MD
Gabrail Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Elise Olsen, MD
Duke University
Shared therapeutic areas:
Worked with same sponsors:
Madeleine Duvic, MD
M.D. Anderson Cancer Center - Dermatology
Shared therapeutic areas:
Worked with same sponsors:
Francesco Turturro, MD
LSU Health Sciences Ctr., Feist-Weiller Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Miles Prince, MD
Cabrini Hospital
Shared therapeutic areas:
Worked with same sponsors:
Andrei R Shustov, MD
Seattle Cancer Care Alliance
Shared therapeutic areas:
Worked with same sponsors:
Neil J Korman, MD, PhD
University Hospitals Case Medical Ctr., Dept. of Dermatology
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma
All 6 trials loaded